Why did Manhattan's Board increase the repurchase authorization from $100 million to $500 million in March 2026?

The filing does not explicitly state the Board's rationale for the increase. However, it occurred alongside strong financial momentum—Q2 2026 saw 26% cloud revenue growth and 23% RPO growth to $2.47 billion—and robust operating cash flow of $174.7 million in the first half, suggesting management confidence in cash generation and capital deployment capacity.

What is the average price Manhattan paid per share in the first half of 2026?

Based on the filing, Manhattan invested $275.0 million to repurchase 1,917,341 shares in the first six months of 2026. This calculates to an average price of approximately $143.43 per share. In Q2 alone, 874,029 shares were repurchased for $125.0 million, or roughly $143 per share.

How much authorization remains for future buybacks?

As of June 30, 2026, approximately $225.0 million remained under the March 2026 repurchase authority of $500 million. At the first-half average execution price of ~$143/share, this provides capacity for approximately 1.6 million additional shares.

Did the buyback impact Manhattan's earnings per share?

Yes. The share repurchase reduced diluted shares outstanding from 61.3 million in H1 2025 to 59.515 million in H1 2026—a reduction of approximately 1.9 million shares or 3%. This reduction mechanically supports EPS growth even if net income is flat or declines on a per-share basis.

How do the buybacks fit within Manhattan's overall capital allocation strategy?

The filing shows Manhattan balancing buybacks with operational investment and debt-free operations. In H1 2026, the company generated $174.7 million in operating cash flow, spent $5.1 million on capex, repurchased $275.0 million in shares, and ended the period with $186.1 million in cash. This suggests capital deployment prioritizes shareholder returns via buybacks while maintaining adequate liquidity.

What execution mechanism does Manhattan use for its repurchases?

The filing discloses share repurchase activity under a publicly-announced buyback program but does not explicitly name the execution mechanism (e.g., Rule 10b-18, 10b5-1 plan, ASR). The language suggests open-market purchases consistent with Rule 10b-18, though the filing itself does not confirm this detail.

MANH 8-K Filed 2026-07-28 Execution disclosure

Manhattan Associates repurchased 1.9M shares for $275M in first half 2026

Q2 execution of 874K shares at $143 average; $225M remains under March 2026 Board authorization

Shares repurchased1.9M

Avg price paid$143.43

Remaining$225M

MechanismRule 10b-18 open-market purcha

What the filing says

Manhattan Associates Inc. (NASDAQ: MANH) repurchased 1,917,341 shares of common stock for a total investment of $275.0 million during the six months ended June 30, 2026, under the share repurchase program authorized by its Board of Directors. In the second quarter alone, the company repurchased 874,029 shares for $125.0 million.

The repurchase activity operates under a Board authorization increased in March 2026 from $100 million to $500 million. As of June 30, 2026, approximately $225.0 million remained available under this authorization. Based on the six-month investment amount, the average price paid per share in the first half of 2026 was approximately $143.43.

The company's buyback activity occurred against a backdrop of strong operational momentum: Q2 2026 revenue reached $297.8 million, up 9% year-over-year, with cloud revenue increasing 26% and remaining performance obligations (RPO) growing 23% to $2.47 billion. The share repurchase reduced the weighted-average diluted share count to 59.515 million for the first half of 2026 from 61.3 million in the prior year period.

During the six months ended June 30, 2026, Manhattan repurchased 1,917,341 shares of its common stock under the share repurchase program authorized by our Board of Directors, for a total investment of $275.0 million. In March 2026, our Board approved an increase to Manhattan's share repurchase authority from $100 million to $500 million. As of the end of the quarter, approximately $225.0 million remained under the existing March 2026 repurchase authority. — MANHATTAN ASSOCIATES INC 8-K filing · View on SEC EDGAR →

What this means

Manhattan's $275 million buyback in the first half of 2026 represents a meaningful deployment of capital, with $225 million of authorization remaining. The repurchase activity reduced diluted shares outstanding by approximately 1.9 million, or roughly 3%, which provides earnings-per-share accretion in a period when the company reported solid operational growth. The March 2026 Board action to increase authorization from $100 million to $500 million signals management confidence in cash generation and capital allocation strategy. With operating cash flow of $174.7 million in the first half and $186.1 million in cash on hand, the company maintains flexibility for ongoing repurchases while funding operations and investing in cloud and AI capabilities.

Frequently asked questions

Why did Manhattan's Board increase the repurchase authorization from $100 million to $500 million in March 2026?: The filing does not explicitly state the Board's rationale for the increase. However, it occurred alongside strong financial momentum—Q2 2026 saw 26% cloud revenue growth and 23% RPO growth to $2.47 billion—and robust operating cash flow of $174.7 million in the first half, suggesting management confidence in cash generation and capital deployment capacity.
What is the average price Manhattan paid per share in the first half of 2026?: Based on the filing, Manhattan invested $275.0 million to repurchase 1,917,341 shares in the first six months of 2026. This calculates to an average price of approximately $143.43 per share. In Q2 alone, 874,029 shares were repurchased for $125.0 million, or roughly $143 per share.
How much authorization remains for future buybacks?: As of June 30, 2026, approximately $225.0 million remained under the March 2026 repurchase authority of $500 million. At the first-half average execution price of ~$143/share, this provides capacity for approximately 1.6 million additional shares.
Did the buyback impact Manhattan's earnings per share?: Yes. The share repurchase reduced diluted shares outstanding from 61.3 million in H1 2025 to 59.515 million in H1 2026—a reduction of approximately 1.9 million shares or 3%. This reduction mechanically supports EPS growth even if net income is flat or declines on a per-share basis.
How do the buybacks fit within Manhattan's overall capital allocation strategy?: The filing shows Manhattan balancing buybacks with operational investment and debt-free operations. In H1 2026, the company generated $174.7 million in operating cash flow, spent $5.1 million on capex, repurchased $275.0 million in shares, and ended the period with $186.1 million in cash. This suggests capital deployment prioritizes shareholder returns via buybacks while maintaining adequate liquidity.
What execution mechanism does Manhattan use for its repurchases?: The filing discloses share repurchase activity under a publicly-announced buyback program but does not explicitly name the execution mechanism (e.g., Rule 10b-18, 10b5-1 plan, ASR). The language suggests open-market purchases consistent with Rule 10b-18, though the filing itself does not confirm this detail.

execution rule-10b-18 mega-cap tech-sector authorization-increase cash-return

Source. This editorial summary is based on the SEC filing linked above. BuybackStocks aggregates and editorializes publicly available SEC EDGAR filings. Not investment advice. Past authorization announcements do not guarantee future repurchase activity or share price performance. See our full disclosures policy.